MedTrace Logo

Whole-body Hyperthermia for Depression

NCT06323785 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-06-11

No results posted yet for this study

Summary

The goal of this clinical trial is to test the efficacy of whole-body hyperthermia in major depression. The main question it aims to answer is:

• Does whole-body hyperthermia alleviate symptoms of depression?

Participants will be randomised to sham or active whole-body hyperthermia. The study will last 6 weeks during which five visits will take place. Depression will be measured repeatedly and biological mechanisms will be investigated.

Conditions

Interventions

DEVICE

Active whole-body hyperthermia

Active water-filtered infrared whole-body hyperthermia as described in Janssen et al. (2016)

DEVICE

Sham whole-body hyperthermia

Sham water-filtered infrared whole-body hyperthermia as described in Janssen et al. (2016)

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • Susanne Fischer, PhD · University of Zurich

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-15
Primary Completion
2026-03-01
Completion
2026-03-01

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06323785 on ClinicalTrials.gov